In silico screening of potential inhibitors from Cordyceps species against SARS-CoV-2 main protease
Description
Coronavirus disease 2019 (COVID-19) is a result of a retroviral infection of SARS-CoV-2. Due to its virulence and high infection rate, it is a matter of serious concern and a global health emergency. Currently available COVID-19 vaccines approved by
